Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufactured by: ...

FDA Drug Recall #D-0655-2025 - Class I, August 27, 2025

Recall Summary

Recall Number D-0655-2025
Classification Class I - Serious risk
Date Initiated August 27, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Unichem Pharmaceuticals USA Inc.
Location East Brunswick, NJ
Product Type Drugs
Quantity 230 90-count bottles

Product Description

Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufactured by: Unichem Laboratories, Ltd, Pilerne Ind. Estate, Pilerne, Bardez, Goa, India; Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ. NDC 29300-415-19.

Reason for Recall

Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).

Distribution Pattern

Nationwide within the U.S.A

Lot / Code Information

Lot No: GMML24026A, Expires: 09/30/2027

Other Recalls from Unichem Pharmaceuticals USA Inc.

Recall # Classification Product Date
D-0511-2026 Class III busPIRone Hydrochloride Tablets, USP, 5 mg, 500... Apr 13, 2026
D-0301-2026 Class II Bisoprolol Fumarate and Hydrochlorothiazide tab... Jan 21, 2026
D-0306-2026 Class III Doxazosin Tablets, USP, 4 mg, 1000 tablets per ... Jan 21, 2026

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.